These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20233649)

  • 21. A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphate.
    Sassaki GL; Riter DS; Santana Filho AP; Guerrini M; Lima MA; Cosentino C; Souza LM; Cipriani TR; Rudd TR; Nader HB; Yates EA; Gorin PA; Torri G; Iacomini M
    Analyst; 2011 Jun; 136(11):2330-8. PubMed ID: 21494716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.
    Beyer T; Diehl B; Randel G; Humpfer E; Schäfer H; Spraul M; Schollmayer C; Holzgrabe U
    J Pharm Biomed Anal; 2008 Sep; 48(1):13-9. PubMed ID: 18678460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
    Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
    Alban S; Lühn S; Schiemann S
    Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the 1H and 15N NMR resonances of sulfamate groups in aqueous solution: a new tool for heparin and heparan sulfate characterization.
    Langeslay DJ; Beni S; Larive CK
    Anal Chem; 2011 Oct; 83(20):8006-10. PubMed ID: 21913677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
    Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
    Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyphenated HPLC-NMR and its applications in drug discovery.
    Peng SX
    Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin.
    Mauri L; Marinozzi M; Mazzini G; Kolinski RE; Karfunkle M; Keire DA; Guerrini M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin.
    Workman WE; Carrick KL
    Front Med (Lausanne); 2019; 6():315. PubMed ID: 31998734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
    Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
    Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadening of 1H NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals.
    McEwen I
    J Pharm Biomed Anal; 2010 Feb; 51(3):733-5. PubMed ID: 19782493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method.
    Sitkowski J; Bednarek E; Bocian W; Kozerski L
    J Med Chem; 2008 Dec; 51(24):7663-5. PubMed ID: 19055319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.
    Rudd TR; Gaudesi D; Skidmore MA; Ferro M; Guerrini M; Mulloy B; Torri G; Yates EA
    Analyst; 2011 Apr; 136(7):1380-9. PubMed ID: 21279243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy.
    Guerrini M; Naggi A; Guglieri S; Santarsiero R; Torri G
    Anal Biochem; 2005 Feb; 337(1):35-47. PubMed ID: 15649373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
    Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
    J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.